Cassava Sciences Files 8-K

TL;DR

Cassava Sciences filed a routine 8-K, no major news.

AI Summary

Cassava Sciences, Inc. filed an 8-K on July 22, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or new material events beyond the standard reporting requirements.

Why It Matters

This 8-K filing indicates routine corporate reporting by Cassava Sciences, Inc. to the SEC, without disclosing new material information that would immediately impact its stock price.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for reporting purposes and does not contain new material information or significant financial updates.

Key Players & Entities

• Cassava Sciences, Inc. (company) — Registrant
• July 22, 2024 (date) — Date of Report
• Delaware (jurisdiction) — State of Incorporation
• 001-41905 (commission_file_number) — SEC File Number
• 91-1911336 (irs_number) — I.R.S. Employer Identification Number
• 6801 N Capital of Texas Highway (address) — Business Address
• Austin, Texas (location) — Business Address City and State

FAQ

Key Financial Figures

• $0.001 — nge on which registered Common Stock, $0.001 par value SAVA Nasdaq Capital Marke

Filing Documents

• sava20240721_8k.htm (8-K) — 33KB
• ex_701112.htm (EX-99.1) — 17KB
• 0001437749-24-023128.txt ( ) — 206KB
• sava-20240722.xsd (EX-101.SCH) — 4KB
• sava-20240722_def.xml (EX-101.DEF) — 14KB
• sava-20240722_lab.xml (EX-101.LAB) — 18KB
• sava-20240722_pre.xml (EX-101.PRE) — 14KB
• sava20240721_8k_htm.xml (XML) — 5KB

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure On July 22, 2024, Rick Barry, Executive Chairman of Cassava Sciences, Inc. issued An Open Letter to the Cassava Community. A copy of the letter is attached as Exhibit 99.1 hereto and incorporated into this Item 7.01 by reference. The information furnished in this Item 7.01 and Exhibit 99.1 attached hereto shall not be deemed to be "filed" for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the " Exchange Act "), or otherwise subject to the liabilities of such section, nor shall such information be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. 9.01: Financial Statements and Exhibits Exhibit No. Description 99.1 An Open Letter to the Cassava Community from Rick Barry, issued July 22, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. CASSAVA SCIENCES, INC. a Delaware corporation Date: July 22, 2024 By: /s/ ERIC J. SCHOEN Eric J. Schoen Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR